Clear Creek Financial Management, LLC Crispr Therapeutics Ag Transaction History

Clear Creek Financial Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 16, 2020	SELL	$38.5 - $76.05 $218,641 - $431,887	-5,679 Closed	0 $0
Q1 2020 Apr 23, 2020	BUY	$33.68 - $62.53 $5,052 - $9,379	150 Added 2.71%	5,679 $300,000
Q3 2019 Nov 15, 2019	SELL	$40.99 - $52.56 $28,733 - $36,844	-701 Reduced 11.25%	5,529 $311,000
Q2 2019 Aug 16, 2019	BUY	$35.45 - $48.2 $220,853 - $300,286	6,230 New	6,230 $293,000

499

56.8M

1.7M

1.8M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.05B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Clear Creek Financial Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Clear Creek Financial Management, LLC with notifications on news.